(Q33964984)

30 July 2017

title

Inflammation-based prognostic scores and nutritional prognostic index in patients with locally-advanced unresectable colorectal cancer (English)

1 reference

30 July 2017

1 reference

1 reference

Masahide Ikeguchi

1

1 reference

30 July 2017

Sho-Ichi Urushibara

2

1 reference

30 July 2017

Ryugo Shimoda

3

1 reference

30 July 2017

Manabu Yamamoto

4

1 reference

30 July 2017

Yoshihiko Maeta

5

1 reference

30 July 2017

Keigo Ashida

6

1 reference

30 July 2017

publication date

15 July 2014

1 reference

World Journal of Surgical Oncology

30 July 2017

published in

1 reference

30 July 2017

volume

12

1 reference

30 July 2017

page(s)

210

1 reference

https://scigraph.springernature.com/pub.10.1186/1477-7819-12-210

30 July 2017

exact match

0 references

cites work

Survival of patients with initially unresectable colorectal liver metastases treated with FOLFOX/cetuximab or FOLFIRI/cetuximab in a multidisciplinary concept (CELIM study).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4114089

Lymphopenia is an independent predictor of inferior outcome in clear cell renal carcinoma

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4114089

The systemic inflammation-based Glasgow Prognostic Score: a decade of experience in patients with cancer.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4114089

Prognostic significance of a systemic inflammatory response in patients receiving first-line palliative chemotherapy for recurred or metastatic gastric cancer.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4114089

Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4114089

Randomized, phase III trial of panitumumab with infusional fluorouracil, leucovorin, and oxaliplatin (FOLFOX4) versus FOLFOX4 alone as first-line treatment in patients with previously untreated metastatic colorectal cancer: the PRIME study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4114089

Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4114089

Quality of life scores as prognostic factors of overall survival in advanced head and neck cancer: analysis of a phase III randomized trial of pemetrexed plus cisplatin versus cisplatin monotherapy

5 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1477-7819-12-210

Modified Glasgow prognostic score in patients with incurable stage IV colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1477-7819-12-210

The baseline ratio of neutrophils to lymphocytes is associated with patient prognosis in advanced gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1477-7819-12-210

Factors that influence survival in unresectable metastatic or locally advanced colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1477-7819-12-210

Treatment with 5-fluorouracil/folinic acid, oxaliplatin, and irinotecan enables surgical resection of metastases in patients with initially unresectable metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1477-7819-12-210

The glasgow prognostic score as a predictor of survival in patients with potentially resectable pancreatic adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1477-7819-12-210

Cancer chemotherapy-induced lymphocytosis: a revolutionary discovery in the medical oncology.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4114089

The prognostic nutritional index can be a prognostic indicator in colorectal carcinoma

29 October 2018

1 reference

12 December 2020

The modified Glasgow Prognostic Score (mGPS) is a good predictor of indication for palliative bypass surgery in patients with unresectable pancreatic and biliary cancers

1 reference

12 December 2020

Lymphocyte subsets in peripheral blood as prognostic factors in colorectal cancer

1 reference

12 December 2020

Evaluations of interferon-γ/interleukin-4 ratio and neutrophil/lymphocyte ratio as prognostic indicators in gastric cancer patients

1 reference

12 December 2020

Conversion chemotherapy using cetuximab plus FOLFIRI followed by bevacizumab plus mFOLFOX6 in patients with unresectable liver metastases from colorectal cancer

1 reference

12 December 2020

Chemotherapy and targeted therapy for patients with initially unresectable colorectal liver metastases, focusing on conversion hepatectomy and long-term survival

1 reference

12 December 2020

Low nutritional prognostic index correlates with poor survival in patients with stage IV colorectal cancer following palliative resection of the primary tumor

1 reference

12 December 2020

Usefulness of monthly chemotherapy for patients with unresectable metastatic colorectal cancer

1 reference

12 December 2020

Decreased total lymphocyte counts in pancreatic cancer: an index of adverse outcome

1 reference

12 December 2020

Identifiers

DOI

10.1186/1477-7819-12-210

1 reference

Dimensions Publication ID

30 July 2017

1 reference

https://scigraph.springernature.com/pub.10.1186/1477-7819-12-210

9 September 2019

1 reference

30 July 2017

1 reference